This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Brown, L. F. Articles by Dvorak, H. F. Search for Related Content PubMed PubMed Citation Articles by Brown, L. F. Articles by Dvorak, H. F.

Vascular Stroma Formation in Carcinoma in Situ, Invasive Carcinoma, and Metastatic Carcinoma of the Breast¹

Departments of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02215

The generation of vascular stroma is essential for solid tumor growth and involves stimulatory and inhibiting factors as well as stromal components that regulate functions such as cellular adhesion, migration, and gene expression. In an effort to obtain a more integrated understanding of vascular stroma formation in breast carcinoma, we examined expression of the angiogenic factor vascular permeability factor (VPF)/vascular endothelial growth factor (VEGF); the VPF/VEGF receptors flt-1 and KDR; thrombospondin-1, which has been reported to inhibit angiogenesis; and the stromal components collagen type I, total fibronectin, ED-A+ fibronectin, versican, and decorin by mRNA in situ hybridization on frozen sections of 113 blocks of breast tissue from 68 patients including 28 sections of breast tissue without malignancy, 18 with in situ carcinomas, 56 with invasive carcinomas, and 8 with metastatic carcinomas. A characteristic expression profile emerged that was remarkably similar in invasive carcinoma, carcinoma in situ, and metastatic carcinoma, with the following characteristics: strong tumor cell expression of VPF/VEGF; strong endothelial cell expression of VPF/VEGF receptors; strong expression of thrombospondin-1 by stromal cells and occasionally by tumor cells; and strong stromal cell expression of collagen type I, total fibronectin, ED-A+ fibronectin, versican, and decorin. The formation of vascular stroma preceded invasion, raising the possibility that tumor cells invade not into normal breast stroma but rather into a richly vascular stroma that they have induced. Similarly, tumor cells at sites of metastasis appear to induce the vascular stroma in which they grow. We conclude that a distinct pattern of mRNA expression characterizes the generation of vascular stroma in breast cancer and that the formation of vascular stroma may play a role not only in growth of the primary tumor but also in invasion and metastasis.

This article has been cited by other articles:

				A. M. LeBeau, W. N. Brennen, S. Aggarwal, and S. R. Denmeade Targeting the cancer stroma with a fibroblast activation protein-activated promelittin protoxin Mol. Cancer Ther., May 1, 2009; 8(5): 1378 - 1386. [Abstract] [Full Text] [PDF]

				K. Al-Nedawi, B. Meehan, R. S. Kerbel, A. C. Allison, and J. Rak Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR PNAS, March 10, 2009; 106(10): 3794 - 3799. [Abstract] [Full Text] [PDF]

				J. Henshaw, B. Mossop, and F. Yuan Relaxin treatment of solid tumors: effects on electric field-mediated gene delivery Mol. Cancer Ther., August 1, 2008; 7(8): 2566 - 2573. [Abstract] [Full Text] [PDF]

				M. Pukkila, A. Kosunen, K. Ropponen, J. Virtaniemi, J. Kellokoski, E. Kumpulainen, R. Pirinen, J. Nuutinen, R. Johansson, and V.-M. Kosma High stromal versican expression predicts unfavourable outcome in oral squamous cell carcinoma J. Clin. Pathol., March 1, 2007; 60(3): 267 - 272. [Abstract] [Full Text] [PDF]

				S. A. Kuznetsova, P. Issa, E. M. Perruccio, B. Zeng, J. M. Sipes, Y. Ward, N. T. Seyfried, H. L. Fielder, A. J. Day, T. N. Wight, et al. Versican-thrombospondin-1 binding in vitro and colocalization in microfibrils induced by inflammation on vascular smooth muscle cells J. Cell Sci., November 1, 2006; 119(21): 4499 - 4509. [Abstract] [Full Text] [PDF]

				C L Wilson, A H Sims, A Howell, C J Miller, and R B Clarke Effects of oestrogen on gene expression in epithelium and stroma of normal human breast tissue. Endocr. Relat. Cancer, June 1, 2006; 13(2): 617 - 628. [Abstract] [Full Text] [PDF]

				S. Y. Eum, Y. W. Lee, B. Hennig, and M. Toborek Interplay between Epidermal Growth Factor Receptor and Janus Kinase 3 Regulates Polychlorinated Biphenyl-Induced Matrix Metalloproteinase-3 Expression and Transendothelial Migration of Tumor Cells Mol. Cancer Res., June 1, 2006; 4(6): 361 - 370. [Abstract] [Full Text] [PDF]

				G. N. Naumov, E. Bender, D. Zurakowski, S.-Y. Kang, D. Sampson, E. Flynn, R. S. Watnick, O. Straume, L. A. Akslen, J. Folkman, et al. A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype. J Natl Cancer Inst, March 1, 2006; 98(5): 316 - 325. [Abstract] [Full Text] [PDF]

				L. A. Diaz Jr., I. Cheong, C. A. Foss, X. Zhang, B. A. Peters, N. Agrawal, C. Bettegowda, B. Karim, G. Liu, K. Khan, et al. Pharmacologic and Toxicologic Evaluation of C. novyi-NT Spores Toxicol. Sci., December 1, 2005; 88(2): 562 - 575. [Abstract] [Full Text] [PDF]

				R. Midgley and D. Kerr Bevacizumab--current status and future directions Ann. Onc., July 1, 2005; 16(7): 999 - 1004. [Abstract] [Full Text] [PDF]

				P. G. Gallagher, Y. Bao, A. Prorock, P. Zigrino, R. Nischt, V. Politi, C. Mauch, B. Dragulev, and J. W. Fox Gene Expression Profiling Reveals Cross-talk between Melanoma and Fibroblasts: Implications for Host-Tumor Interactions in Metastasis Cancer Res., May 15, 2005; 65(10): 4134 - 4146. [Abstract] [Full Text] [PDF]

				W.-B. Huang, X.-J. Zhou, J.-Y. Chen, L.-H. Zhang, K. Meng, H.-H. Ma, and Z.-F. Lu CD10-positive Stromal Cells in Gastric Carcinoma: Correlation with Invasion and Metastasis Jpn. J. Clin. Oncol., May 1, 2005; 35(5): 245 - 250. [Abstract] [Full Text] [PDF]

				R. Chen, S. Pan, T. A. Brentnall, and R. Aebersold Proteomic Profiling of Pancreatic Cancer for Biomarker Discovery Mol. Cell. Proteomics, April 1, 2005; 4(4): 523 - 533. [Abstract] [Full Text] [PDF]

				X. Zhang, E. Galardi, M. Duquette, M. Delic, J. Lawler, and S. Parangi Antiangiogenic Treatment with the Three Thrombospondin-1 Type 1 Repeats Recombinant Protein in an Orthotopic Human Pancreatic Cancer Model Clin. Cancer Res., March 15, 2005; 11(6): 2337 - 2344. [Abstract] [Full Text] [PDF]

				M.A. GRANT and R. KALLUR Structural Basis for the Functions of Endogenous Angiogenesis Inhibitors Cold Spring Harb Symp Quant Biol, January 1, 2005; 70(0): 399 - 417. [Abstract] [PDF]

				A. Ambesi, R. M. Klein, K. M. Pumiglia, and P. J. McKeown-Longo Anastellin, a Fragment of the First Type III Repeat of Fibronectin, Inhibits Extracellular Signal-Regulated Kinase and Causes G1 Arrest in Human Microvessel Endothelial Cells Cancer Res., January 1, 2005; 65(1): 148 - 156. [Abstract] [Full Text] [PDF]

				R. Namba, J. E. Maglione, L. J.T. Young, A. D. Borowsky, R. D. Cardiff, C. L. MacLeod, and J. P. Gregg Molecular Characterization of the Transition to Malignancy in a Genetically Engineered Mouse-Based Model of Ductal Carcinoma In situ Mol. Cancer Res., August 1, 2004; 2(8): 453 - 463. [Abstract] [Full Text] [PDF]

				J. Koninger, N. A. Giese, F. F. di Mola, P. Berberat, T. Giese, I. Esposito, M. G. Bachem, M. W. Buchler, and H. Friess Overexpressed Decorin in Pancreatic Cancer: Potential Tumor Growth Inhibition and Attenuation of Chemotherapeutic Action Clin. Cancer Res., July 15, 2004; 10(14): 4776 - 4783. [Abstract] [Full Text] [PDF]

				M J Pukkila, A S T Kosunen, J A Virtaniemi, E J Kumpulainen, R T Johansson, J K Kellokoski, J Nuutinen, and V-M Kosma Versican expression in pharyngeal squamous cell carcinoma: an immunohistochemical study J. Clin. Pathol., July 1, 2004; 57(7): 735 - 739. [Abstract] [Full Text] [PDF]

				R. T. Poon, K. K. Chung, S. T. Cheung, C. P. Lau, S. W. Tong, K. L. Leung, W. C. Yu, G. P. Tuszynski, and S. T. Fan Clinical Significance of Thrombospondin 1 Expression in Hepatocellular Carcinoma Clin. Cancer Res., June 15, 2004; 10(12): 4150 - 4157. [Abstract] [Full Text] [PDF]

				K. Sengupta, S. Banerjee, N. K. Saxena, and S. K. Banerjee Thombospondin-1 Disrupts Estrogen-Induced Endothelial Cell Proliferation and Migration and Its Expression Is Suppressed by Estradiol Mol. Cancer Res., March 1, 2004; 2(3): 150 - 158. [Abstract] [Full Text] [PDF]

				A. G. Banerjee, I. Bhattacharyya, W. M. Lydiatt, and J. K. Vishwanatha Aberrant Expression and Localization of Decorin in Human Oral Dysplasia and Squamous Cell Carcinoma Cancer Res., November 15, 2003; 63(22): 7769 - 7776. [Abstract] [Full Text] [PDF]

				R. E. Bachelder, E. A. Lipscomb, X. Lin, M. A. Wendt, N. H. Chadborn, B. J. Eickholt, and A. M. Mercurio Competing Autocrine Pathways Involving Alternative Neuropilin-1 Ligands Regulate Chemotaxis of Carcinoma Cells Cancer Res., September 1, 2003; 63(17): 5230 - 5233. [Abstract] [Full Text] [PDF]

				G. Davies, J. Salter, M. Hills, L.-A. Martin, N. Sacks, and M. Dowsett Correlation between Cyclooxygenase-2 Expression and Angiogenesis in Human Breast Cancer Clin. Cancer Res., July 1, 2003; 9(7): 2651 - 2656. [Abstract] [Full Text] [PDF]

				A J Rice, M A Steward, and C M Quinn Thrombospondin 1 protein expression relates to good prognostic indices in ductal carcinoma in situ of the breast J. Clin. Pathol., December 1, 2002; 55(12): 921 - 925. [Abstract] [Full Text] [PDF]

				J. A. Tuxhorn, G. E. Ayala, M. J. Smith, V. C. Smith, T. D. Dang, and D. R. Rowley Reactive Stroma in Human Prostate Cancer: Induction of Myofibroblast Phenotype and Extracellular Matrix Remodeling Clin. Cancer Res., September 1, 2002; 8(9): 2912 - 2923. [Abstract] [Full Text] [PDF]

				A Rice and C M Quinn Angiogenesis, thrombospondin, and ductal carcinoma in situ of the breast J. Clin. Pathol., August 1, 2002; 55(8): 569 - 574. [Abstract] [Full Text] [PDF]

				J. Chung, R. E. Bachelder, E. A. Lipscomb, L. M. Shaw, and A. M. Mercurio Integrin ({alpha}6{beta}4) regulation of eIF-4E activity and VEGF translation: a survival mechanism for carcinoma cells J. Cell Biol., July 8, 2002; 158(1): 165 - 174. [Abstract] [Full Text] [PDF]

				M. A. Nash, M. T. Deavers, and R. S. Freedman The Expression of Decorin in Human Ovarian Tumors Clin. Cancer Res., June 1, 2002; 8(6): 1754 - 1760. [Abstract] [Full Text] [PDF]

				W. L. Monsky, C. M. Carreira, Y. Tsuzuki, T. Gohongi, D. Fukumura, and R. K. Jain Role of Host Microenvironment in Angiogenesis and Microvascular Functions in Human Breast Cancer Xenografts: Mammary Fat Pad versus Cranial Tumors Clin. Cancer Res., April 1, 2002; 8(4): 1008 - 1013. [Abstract] [Full Text] [PDF]

				A. J. Guidi, D. A. Berry, G. Broadwater, B. Helmchen, I. J. Bleiweiss, D. R. Budman, I. C. Henderson, L. Norton, and D. F. Hayes Association of Angiogenesis and Disease Outcome in Node-Positive Breast Cancer Patients Treated With Adjuvant Cyclophosphamide, Doxorubicin, and Fluorouracil: A Cancer and Leukemia Group B Correlative Science Study From Protocols 8541/8869 J. Clin. Oncol., February 1, 2002; 20(3): 732 - 742. [Abstract] [Full Text] [PDF]

				M. Touab, J. Villena, C. Barranco, M. Arumi-Uria, and A. Bassols Versican Is Differentially Expressed in Human Melanoma and May Play a Role in Tumor Development Am. J. Pathol., February 1, 2002; 160(2): 549 - 557. [Abstract] [Full Text] [PDF]

				L. Desnoyers, D. Arnott, and D. Pennica WISP-1 Binds to Decorin and Biglycan J. Biol. Chem., December 7, 2001; 276(50): 47599 - 47607. [Abstract] [Full Text] [PDF]

				J. Lawler, W.-M. Miao, M. Duquette, N. Bouck, R. T. Bronson, and R. O. Hynes Thrombospondin-1 Gene Expression Affects Survival and Tumor Spectrum of p53-Deficient Mice Am. J. Pathol., November 1, 2001; 159(5): 1949 - 1956. [Abstract] [Full Text] [PDF]

				K. Heer, H. Kumar, J. R. Read, J. N. Fox, J. R. T. Monson, and M. J. Kerin Serum Vascular Endothelial Growth Factor in Breast Cancer: Its Relation with Cancer Type and Estrogen Receptor Status Clin. Cancer Res., November 1, 2001; 7(11): 3491 - 3494. [Abstract] [Full Text] [PDF]

				J. C. Rodriguez-Manzaneque, T. F. Lane, M. A. Ortega, R. O. Hynes, J. Lawler, and M. L. Iruela-Arispe Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor PNAS, October 12, 2001; (2001) 171460498. [Abstract] [Full Text] [PDF]

				E. Fosslien Molecular Pathology of Cyclooxygenase-2 in Cancer-induced Angiogenesis Ann. Clin. Lab. Sci., October 1, 2001; 31(4): 325 - 348. [Abstract] [Full Text] [PDF]

				R. E. Bachelder, A. Crago, J. Chung, M. A. Wendt, L. M. Shaw, G. Robinson, and A. M. Mercurio Vascular Endothelial Growth Factor Is an Autocrine Survival Factor for Neuropilin-expressing Breast Carcinoma Cells Cancer Res., August 1, 2001; 61(15): 5736 - 5740. [Abstract] [Full Text] [PDF]

				R. K. Narla, C.-L. Chen, Y. Dong, and F. M. Uckun In Vivo Antitumor Activity of Bis(4,7-dimethyl-1,10-phenanthroline) Sulfatooxovanadium(IV) {METVAN [VO(SO4)(Me2-Phen)2]} Clin. Cancer Res., July 1, 2001; 7(7): 2124 - 2133. [Abstract] [Full Text] [PDF]

				A. Pluen, Y. Boucher, S. Ramanujan, T. D. McKee, T. Gohongi, E. di Tomaso, E. B. Brown, Y. Izumi, R. B. Campbell, D. A. Berk, et al. Role of tumor-host interactions in interstitial diffusion of macromolecules: Cranial vs. subcutaneous tumors PNAS, March 22, 2001; (2001) 81626898. [Abstract] [Full Text]

				R. Reeves, D. D. Edberg, and Y. Li Architectural Transcription Factor HMGI(Y) Promotes Tumor Progression and Mesenchymal Transition of Human Epithelial Cells Mol. Cell. Biol., January 15, 2001; 21(2): 575 - 594. [Abstract] [Full Text]

				S. P. Gunningham, M. J. Currie, C. Han, B. A. Robinson, P. A. E. Scott, A. L. Harris, and S. B. Fox The Short Form of the Alternatively Spliced flt-4 but not Its Ligand Vascular Endothelial Growth Factor C Is Related to Lymph Node Metastasis in Human Breast Cancers Clin. Cancer Res., November 1, 2000; 6(11): 4278 - 4286. [Abstract] [Full Text] [PDF]

				B. J. Rybarczyk and P. J. Simpson-Haidaris Fibrinogen Assembly, Secretion, and Deposition into Extracellular Matrix by MCF-7 Human Breast Carcinoma Cells Cancer Res., April 1, 2000; 60(7): 2033 - 2039. [Abstract] [Full Text]

				G. Gasparini Prognostic Value of Vascular Endothelial Growth Factor in Breast Cancer Oncologist, April 1, 2000; 5(90001): 37 - 44. [Abstract] [Full Text]

				A. J. Guidi, D. A. Berry, G. Broadwater, M. Perloff, L. Norton, M. P. Barcos, and D. F. Hayes Association of Angiogenesis in Lymph Node Metastases With Outcome of Breast Cancer J Natl Cancer Inst, March 15, 2000; 92(6): 486 - 492. [Abstract] [Full Text] [PDF]

				A. Pluen, Y. Boucher, S. Ramanujan, T. D. McKee, T. Gohongi, E. di Tomaso, E. B. Brown, Y. Izumi, R. B. Campbell, D. A. Berk, et al. Role of tumor-host interactions in interstitial diffusion of macromolecules: Cranial vs. subcutaneous tumors PNAS, April 10, 2001; 98(8): 4628 - 4633. [Abstract] [Full Text] [PDF]

				J. C. Rodriguez-Manzaneque, T. F. Lane, M. A. Ortega, R. O. Hynes, J. Lawler, and M. L. Iruela-Arispe Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor PNAS, October 23, 2001; 98(22): 12485 - 12490. [Abstract] [Full Text] [PDF]